These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Premature Coronary Artery Disease due to Homozygous Familial Hypercholesterolemia in a 12-Year-Old Girl. Ekici F; Özçobanoğlu S; Kardelen F Balkan Med J; 2018 Mar; 35(2):208-211. PubMed ID: 29072176 [TBL] [Abstract][Full Text] [Related]
6. The effect of lomitapide on cardiovascular outcome measures in homozygous familial hypercholesterolemia: A modelling analysis. Leipold R; Raal F; Ishak J; Hovingh K; Phillips H Eur J Prev Cardiol; 2017 Nov; 24(17):1843-1850. PubMed ID: 28925748 [TBL] [Abstract][Full Text] [Related]
7. Real-World Effectiveness of PCSK9 Inhibitors in Reducing LDL-C in Patients With Familial Hypercholesterolemia in Italy: A Retrospective Cohort Study Based on the AIFA Monitoring Registries. Arca M; Celant S; Olimpieri PP; Colatrella A; Tomassini L; D'Erasmo L; Averna M; Zambon A; Catapano AL; Russo P J Am Heart Assoc; 2023 Nov; 12(21):e026550. PubMed ID: 37850449 [TBL] [Abstract][Full Text] [Related]
8. Complementary role of evinacumab in combination with lipoprotein apheresis in patients with homozygous familial hypercholesterolemia. Duell PB; Warden BA Ther Apher Dial; 2022 Dec; 26 Suppl 1():12-17. PubMed ID: 36468314 [TBL] [Abstract][Full Text] [Related]
9. LDL-C-Lowering Therapies for Adults and Children With Homozygous Familial Hypercholesterolemia: Challenges and Successes. Santos RD; Cuchel M Circulation; 2024 Jan; 149(5):363-366. PubMed ID: 38285739 [No Abstract] [Full Text] [Related]
10. Homozygous Familial Hypercholesterolemia Associated with Symmetric Subcutaneous Lipomatosis. Dawoud NM; Bakry OA; Seleit I Indian J Dermatol; 2015; 60(4):420. PubMed ID: 26288434 [TBL] [Abstract][Full Text] [Related]
11. An Interesting Case of Familial Homozygous Hypercholesterolemia-A Brief Review. Jayaram S; Meera S; Kadi S; Sreenivasa N Indian J Clin Biochem; 2012 Jul; 27(3):309-13. PubMed ID: 26405394 [TBL] [Abstract][Full Text] [Related]
12. Very High Cholesterol Mimicking Homozygous Familial Hypercholesterolemia. Shotwell MK; Vorla M; Kalra DK Circulation; 2022 Oct; 146(15):1182-1188. PubMed ID: 36214132 [No Abstract] [Full Text] [Related]
13. Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts. Basu SK; Goldstein JL; Anderson GW; Brown MS Proc Natl Acad Sci U S A; 1976 Sep; 73(9):3178-82. PubMed ID: 184464 [TBL] [Abstract][Full Text] [Related]
14. The clinical and molecular diversity of homozygous familial hypercholesterolemia in children: Results from the GeneTics of clinical homozygous hypercholesterolemia (GoTCHA) study. Luirink IK; Braamskamp MJAM; Wiegman A; Hartgers ML; Sjouke B; Defesche JC; Hovingh GK J Clin Lipidol; 2019; 13(2):272-278. PubMed ID: 30795984 [TBL] [Abstract][Full Text] [Related]
15. Implementation of Novel Lipid Therapies in a Refractory Heterozygous Familial Hypercholesterolemia Patient With Atherosclerotic Disease. Weintraub SF; Schillow JA; Azari BM; Hirsh BJ JACC Case Rep; 2022 Oct; 4(20):1327-1330. PubMed ID: 36299643 [TBL] [Abstract][Full Text] [Related]
16. The use of high-resolution MRI to detect thrombosis and lipid-rich carotid artery plaques in a patient with homozygous familial hypercholesterolemia. Wang Z; Liu W; Jiang L; Wang L; Yu W Rev Assoc Med Bras (1992); 2020; 66(1):31-35. PubMed ID: 32130378 [TBL] [Abstract][Full Text] [Related]
17. Novel Presentation of Homozygous Familial Hypercholesterolemia With Homozygous Variants in Both LDLR and APOB Genes. Derenbecker R; Kapoor K; Brown E; Leucker T; Jones SR; Lokhandwala PM; Byrne KH; Martin SS JACC Case Rep; 2019 Oct; 1(3):346-349. PubMed ID: 34316823 [TBL] [Abstract][Full Text] [Related]
18. Multiple Xanthoma Tuberosum in a Case of Familial Homozygous Hypercholesterolemia. Singhania P; Biswas P; Dhar A J ASEAN Fed Endocr Soc; 2023; 38(1):134-135. PubMed ID: 37252422 [No Abstract] [Full Text] [Related]
19. Toward a new clinical classification of patients with familial hypercholesterolemia: One perspective from Spain. Masana L; Ibarretxe D; Rodríguez-Borjabad C; Plana N; Valdivielso P; Pedro-Botet J; Civeira F; López-Miranda J; Guijarro C; Mostaza J; Pintó X; Atherosclerosis; 2019 Aug; 287():89-92. PubMed ID: 31238171 [TBL] [Abstract][Full Text] [Related]
20. Lessons learned from the evinacumab trials in the treatment of homozygous familial hypercholesterolemia. Khoury E; Croteau L; Lauzière A; Gaudet D Future Cardiol; 2022 Jun; 18(6):507-518. PubMed ID: 35469449 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]